# LeMaitre Vascular, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/lemaitre-vascular-inc/b7461758-e3aa-4103-8d51-58c729f0c3cd

> Inspection records and compliance data for LeMaitre Vascular, Inc. in Burlington, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: LeMaitre Vascular, Inc.
- FEI Number: 1220948
- City: Burlington
- State: Massachusetts
- Country Name: United States
- Address Line 1: 32 3rd Ave
- Zip Code: 01803

## Related Documents

- [483 - LeMaitre Vascular, Inc. - 2025-04-16](https://www.keypedia.com/records/483/lemaitre-vascular-inc/e0339b23-6de1-4a51-b6ff-40150495525a) — source: FDA, date: April 16, 2025
- [483 - LeMaitre Vascular, Inc. - 2025-04-16](https://www.keypedia.com/records/483/lemaitre-vascular-inc/71daf5d7-70d2-4a92-b286-506ae7d9cfdf) — source: FDA, date: April 16, 2025
- [WARNING_LETTER - LeMaitre Vascular, Inc. - 2025-04-16](https://www.keypedia.com/records/warning_letter/lemaitre-vascular-inc/3000c09b-7700-4856-95f0-dba90be8ec1e) — source: FDA, date: April 16, 2025
- [483 - LeMaitre Vascular, Inc. - 2024-05-15](https://www.keypedia.com/records/483/lemaitre-vascular-inc/f6ab0c82-336e-4df7-bb0d-6caa6c2531a0) — source: FDA, date: May 15, 2024
- [483 - LeMaitre Vascular, Inc. - 2023-05-16](https://www.keypedia.com/records/483/lemaitre-vascular-inc/b27b211f-dee9-4c29-8082-9ed4b6ffe155) — source: FDA, date: May 16, 2023
- [FDA Inspection 1206543 - LeMaitre Vascular, Inc. - 2023-05-16](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/0d85c2e6-3c6a-4885-90e7-1d8709edfa0b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 16, 2023
- [483 - LeMaitre Vascular, Inc. - 2022-11-14](https://www.keypedia.com/records/483/lemaitre-vascular-inc/679132eb-f77c-4267-b629-40da54d61d18) — source: FDA, date: November 14, 2022
- [FDA Inspection 1172108 - LeMaitre Vascular, Inc. - 2022-06-15](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/e426d7a8-1601-43db-8fa4-0cf83f6e8636) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 15, 2022
- [FDA Inspection 1148251 - LeMaitre Vascular, Inc. - 2021-07-26](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/9e693354-7765-4ca3-852d-482e976e25aa) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2021
- [FDA Inspection 1148251 - LeMaitre Vascular, Inc. - 2021-07-26](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/7540e6a5-6627-4703-946e-401289a67486) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2021
- [FDA Inspection 1129204 - LeMaitre Vascular, Inc. - 2020-08-27](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/2c1189c4-a231-4cc3-8013-740f42ba51c2) — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2020
- [FDA Inspection 1023176 - LeMaitre Vascular, Inc. - 2017-08-01](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/73fd6054-ea90-471d-91c2-dddfcb60c1bd) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2017
- [FDA Inspection 823948 - LeMaitre Vascular, Inc. - 2013-03-04](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/b1caf42a-bae3-4fab-aee1-d4ee47a0a1a4) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2013
- [FDA Inspection 823948 - LeMaitre Vascular, Inc. - 2013-03-04](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/ddebdfdc-0a88-4e6f-8f1a-af1182a321a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 4, 2013
- [FDA Inspection 808236 - LeMaitre Vascular, Inc. - 2012-10-31](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/53a3fd81-429e-4284-8413-f4f9b2a96653) — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2012
- [FDA Inspection 808236 - LeMaitre Vascular, Inc. - 2012-10-31](https://www.keypedia.com/records/fda_inspections/lemaitre-vascular-inc/c6d41af7-ee35-48f2-ba58-058f1dd022a9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2012

## Related Companies

- [Novo Nordisk Inc.](https://www.keypedia.com/companies/novo-nordisk-inc/920bb4ea-9450-45a6-bcd7-9f85c2f2bbad)
- [Albanese Confectionery Group, Inc.](https://www.keypedia.com/companies/albanese-confectionery-group-inc/710e8461-bf4c-42de-b5b6-f1873dab783f)
- [Children's National Medical Center IRB](https://www.keypedia.com/companies/childrens-national-medical-center-irb/b85c818b-4db6-4f98-a73b-5ba95b927999)
- [Human Biosciences, Inc.](https://www.keypedia.com/companies/human-biosciences-inc/1396dcaa-6c36-4bff-910b-20937317db70)
- [Valley View Milling LLC](https://www.keypedia.com/companies/valley-view-milling-llc/a61f0ea1-b79b-4642-acd4-e0cc5540c7e6)
- [LISI MEDICAL Remmele, Inc](https://www.keypedia.com/companies/lisi-medical-remmele-inc/5db0d935-dd79-4f93-9b48-cb429353e242)
- [Maquet SAS](https://www.keypedia.com/companies/maquet-sas/7e2d533e-d7fc-4715-b60c-928657757140)
- [Arrow Reliance Inc](https://www.keypedia.com/companies/arrow-reliance-inc/9bb8344e-4728-4988-b0bb-b66d7f5fc079)
- [iRhythm Technologies Inc](https://www.keypedia.com/companies/irhythm-technologies-inc/fb230c01-1845-46a2-82fa-5eda280fcc0c)
- [Alexion Pharmaceuticals, Inc.](https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015)

## Related Officers

- [Gregory Stone](https://www.keypedia.com/people/gregory-stone/6fc15653-2d1b-46d6-89dd-655a40ea72de)
- [Sunita Pandey](https://www.keypedia.com/people/sunita-pandey/008e5bb8-0eb3-45d8-8524-734ac0454250)
- [Drug Investigator](https://www.keypedia.com/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)